Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach

Description

Purpose is to study the clinical outcomes of Clareon Vivity and Clareon Vivity Toric intraocular lens (IOL) implants in patients who are planning to have cataract surgery in both eyes with a mini-monovision approach.

Conditions

Aphakia, Postcataract

Talk to us

Study Overview

On this page

Study Details

Study overview

Purpose is to study the clinical outcomes of Clareon Vivity and Clareon Vivity Toric intraocular lens (IOL) implants in patients who are planning to have cataract surgery in both eyes with a mini-monovision approach.

Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach

Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach

Condition
Aphakia, Postcataract
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Palo Alto Medical Foundation, Palo Alto, California, United States, 94301

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult patients with bilateral age-related visually significant cataracts in otherwise healthy eyes, undergoing bilateral sequential implantation within 21 days using Clareon Vivity and Clareon Vivity Torics
  • * IOL powers between +10D to +30.0D, T3-T6
  • * Potential acuity measured post-operatively 20/25 or better in both eyes
  • * History of ocular or refractive surgery
  • * Ocular or systemic comorbidities that may alter or reduce visual acuity, contrast sensitivity, binocularity, or impair reading performance such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, strabismus/amblyopia etc.
  • * Patients with irregular astigmatism, corneal dystrophies, pupil abnormalities, zonular laxity
  • * Intraoperative or postoperative complications

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Debbie S. Kuo, MD,

Study Record Dates

2026-06